Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
NCT ID: NCT04847895
Last Updated: 2021-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5500 participants
OBSERVATIONAL
2015-06-01
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observation of Treatment Patterns With Lucentis in Approved Indications
NCT02194803
Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD
NCT01269151
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
NCT01370135
Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.
NCT01831947
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
NCT01318941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The baseline visit will be used to assess eligibility and collect baseline characteristics information. The follow-up visits will take place at a frequency defined as per investigator's discretion.
The study eye is defined as the first eye treated during the study, the other eye will be considered as the fellow eye. If both eyes are treated at baseline, the right eye will be chosen as the study eye.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lucentis
Patients administered Lucentis by prescription
Lucentis
There is no treatment allocation. Patients administered Lucentis by prescription that have started before inclusion of the patient into the study will be enrolled.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lucentis
There is no treatment allocation. Patients administered Lucentis by prescription that have started before inclusion of the patient into the study will be enrolled.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
Exclusion Criteria
* Participation in any other clinical study or NIS with Lucentis® as the investigational drug (such as OCEAN or LUMINOUS)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Novartis Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novartis Investigative Site
Ettlingen, Baden-Wurttemberg, Germany
Novartis Investigative Site
Ahaus, , Germany
Novartis Investigative Site
Andernach, , Germany
Novartis Investigative Site
Augsburg, , Germany
Novartis Investigative Site
Augsburg, , Germany
Novartis Investigative Site
Bad Arolsen-Meneringhausen, , Germany
Novartis Investigative Site
Bad Liebenzell, , Germany
Novartis Investigative Site
Bad Säckingen, , Germany
Novartis Investigative Site
Baden-Baden, , Germany
Novartis Investigative Site
Bautzen, , Germany
Novartis Investigative Site
Beckum, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Berlin, , Germany
Novartis Investigative Site
Bielefeld, , Germany
Novartis Investigative Site
Bonn, , Germany
Novartis Investigative Site
Borna, , Germany
Novartis Investigative Site
Braunschweig, , Germany
Novartis Investigative Site
Breisach, , Germany
Novartis Investigative Site
Bremen, , Germany
Novartis Investigative Site
Bremerhaven, , Germany
Novartis Investigative Site
Bremerhaven, , Germany
Novartis Investigative Site
Bremervörde, , Germany
Novartis Investigative Site
Brühl, , Germany
Novartis Investigative Site
Buchholz, , Germany
Novartis Investigative Site
Buxtehude, , Germany
Novartis Investigative Site
Celle, , Germany
Novartis Investigative Site
Cham, , Germany
Novartis Investigative Site
Chemnitz, , Germany
Novartis Investigative Site
Chemnitz, , Germany
Novartis Investigative Site
Cologne, , Germany
Novartis Investigative Site
Coswig, , Germany
Novartis Investigative Site
Dannenberg, , Germany
Novartis Investigative Site
Darmstadt, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Dresden, , Germany
Novartis Investigative Site
Düsseldorf, , Germany
Novartis Investigative Site
Düsseldorf, , Germany
Novartis Investigative Site
Düsseldorf, , Germany
Novartis Investigative Site
Eckental, , Germany
Novartis Investigative Site
Ehingen, , Germany
Novartis Investigative Site
Einbeck, , Germany
Novartis Investigative Site
Erding, , Germany
Novartis Investigative Site
Erkrath, , Germany
Novartis Investigative Site
Esslingen am Neckar, , Germany
Novartis Investigative Site
Frankenthal, , Germany
Novartis Investigative Site
Frankfurt, , Germany
Novartis Investigative Site
Frankfurt am Main, , Germany
Novartis Investigative Site
Freudenstadt, , Germany
Novartis Investigative Site
Friedberg, , Germany
Novartis Investigative Site
Fulda, , Germany
Novartis Investigative Site
Garching, , Germany
Novartis Investigative Site
Glauchau, , Germany
Novartis Investigative Site
Göttingen, , Germany
Novartis Investigative Site
Göttingen, , Germany
Novartis Investigative Site
Gütersloh, , Germany
Novartis Investigative Site
Halle, , Germany
Novartis Investigative Site
Halle, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Hamburg, , Germany
Novartis Investigative Site
Heidelberg, , Germany
Novartis Investigative Site
Heppenheim an der Bergstrasse, , Germany
Novartis Investigative Site
Herrsching am Ammersee, , Germany
Novartis Investigative Site
Herzberg, , Germany
Novartis Investigative Site
Homburg, , Germany
Novartis Investigative Site
Hoppegarten, , Germany
Novartis Investigative Site
Höhr-Grenzhausen, , Germany
Novartis Investigative Site
Hösbach, , Germany
Novartis Investigative Site
Jülich, , Germany
Novartis Investigative Site
Kaiserslautern, , Germany
Novartis Investigative Site
Karlsruhe, , Germany
Novartis Investigative Site
Kempten, , Germany
Novartis Investigative Site
Kiel, , Germany
Novartis Investigative Site
Koblenz, , Germany
Novartis Investigative Site
Leer, , Germany
Novartis Investigative Site
Leipzig, , Germany
Novartis Investigative Site
Leipzig, , Germany
Novartis Investigative Site
Ludwigshafen, , Germany
Novartis Investigative Site
Ludwigshafen, , Germany
Novartis Investigative Site
Lübeck, , Germany
Novartis Investigative Site
Mainz, , Germany
Novartis Investigative Site
Mainz, , Germany
Novartis Investigative Site
Mainz, , Germany
Novartis Investigative Site
Meiben, , Germany
Novartis Investigative Site
Minden, , Germany
Novartis Investigative Site
Moers, , Germany
Novartis Investigative Site
Mutterstadt, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
München, , Germany
Novartis Investigative Site
Münster, , Germany
Novartis Investigative Site
Münster, , Germany
Novartis Investigative Site
Neu-Ulm, , Germany
Novartis Investigative Site
Neubrandenburg, , Germany
Novartis Investigative Site
Neubrandenburg, , Germany
Novartis Investigative Site
Neustadt, , Germany
Novartis Investigative Site
Neustadt A. D. Weinstraße, , Germany
Novartis Investigative Site
Neutraubling, , Germany
Novartis Investigative Site
Neuwied, , Germany
Novartis Investigative Site
Nuremberg, , Germany
Novartis Investigative Site
Obernkirchen, , Germany
Novartis Investigative Site
Offenburg, , Germany
Novartis Investigative Site
Oldenburg, , Germany
Novartis Investigative Site
Oldenburg, , Germany
Novartis Investigative Site
Osnabrück, , Germany
Novartis Investigative Site
Paderborn, , Germany
Novartis Investigative Site
Paderborn, , Germany
Novartis Investigative Site
Peine, , Germany
Novartis Investigative Site
Pfaffenhofen, , Germany
Novartis Investigative Site
Pirna, , Germany
Novartis Investigative Site
Plauen, , Germany
Novartis Investigative Site
Polch, , Germany
Novartis Investigative Site
Prien am Chiemsee, , Germany
Novartis Investigative Site
Quakenbrück, , Germany
Novartis Investigative Site
Raesfeld, , Germany
Novartis Investigative Site
Ratingen, , Germany
Novartis Investigative Site
Regensburg, , Germany
Novartis Investigative Site
Rhauderfehn, , Germany
Novartis Investigative Site
Rheine, , Germany
Novartis Investigative Site
Rostock, , Germany
Novartis Investigative Site
Rüsselsheim am Main, , Germany
Novartis Investigative Site
Saarbrücken, , Germany
Novartis Investigative Site
Saarbrücken, , Germany
Novartis Investigative Site
Saarburg, , Germany
Novartis Investigative Site
Saarlouis, , Germany
Novartis Investigative Site
Salzgitter, , Germany
Novartis Investigative Site
Schweinfurt, , Germany
Novartis Investigative Site
Siegen, , Germany
Novartis Investigative Site
Sindelfingen, , Germany
Novartis Investigative Site
Speyer, , Germany
Novartis Investigative Site
Straubing, , Germany
Novartis Investigative Site
Torgau, , Germany
Novartis Investigative Site
Trier, , Germany
Novartis Investigative Site
Troisdorf, , Germany
Novartis Investigative Site
Tübingen, , Germany
Novartis Investigative Site
Ulm, , Germany
Novartis Investigative Site
Waldshut-Tiengen, , Germany
Novartis Investigative Site
Wedel, , Germany
Novartis Investigative Site
Westerstede, , Germany
Novartis Investigative Site
Wismar, , Germany
Novartis Investigative Site
Worms, , Germany
Novartis Investigative Site
Würzburg, , Germany
Novartis Investigative Site
Bergen op Zoom, North Brabant, Netherlands
Novartis Investigative Site
Heerhugowaard, North Holland, Netherlands
Novartis Investigative Site
's-Hertogenbosch, , Netherlands
Novartis Investigative Site
Deventer, , Netherlands
Novartis Investigative Site
Rotterdam, , Netherlands
Novartis Investigative Site
Rotterdam, , Netherlands
Novartis Investigative Site
Terneuzen, , Netherlands
Novartis Investigative Site
Tilburg, , Netherlands
Novartis Investigative Site
Bern, Canton of Bern, Switzerland
Novartis Investigative Site
Neuchâtel, Canton of Neuchâtel, Switzerland
Novartis Investigative Site
Wil, Canton of St. Gallen, Switzerland
Novartis Investigative Site
Aarau, , Switzerland
Novartis Investigative Site
Basel, , Switzerland
Novartis Investigative Site
Basel, , Switzerland
Novartis Investigative Site
Fribourg, , Switzerland
Novartis Investigative Site
Geneva, , Switzerland
Novartis Investigative Site
Geneva, , Switzerland
Novartis Investigative Site
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRFB002ADE28
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.